NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

Aripiprazole (Abilify) has a lower risk of:

  1. Neuroleptic malignant syndrome

  2. Weight gain

  3. QT prolongation in adults

  4. Agranulocytosis

The correct answer is: Weight gain

Aripiprazole (Abilify) has a lower risk of weight gain compared to other antipsychotic medications. While neuroleptic malignant syndrome, QT prolongation in adults, and agranulocytosis are potential side effects of antipsychotic medications, they are not the focus of this question. This question specifically asks about the potential for weight gain with Aripiprazole, and therefore options A, C, and D are incorrect. It is important to note, however, that all medications can have potential side effects and it is important to discuss any concerns with a healthcare provider.

More Questions Like This